This inventor holds 1 USPTO granted patent. Top assignee: Casebia Therapeutics Limited Liability Partnership. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wayne Coco and His Patent in RNA-Programmable Endonuclease Systems.
Introduction
Wayne Coco is an inventor associated with Cologne, Germany. His listed patent work concerns RNA-programmable endonuclease systems, a technology area relevant to genome editing.
Latest Patents
Coco is credited with 1 patent: “Novel High Fidelity RNA-Programmable Endonuclease Systems and Uses Thereof.” The patent describes systems and applications involving RNA-programmable endonucleases.
Career Highlights
Coco is associated with Casebia Therapeutics Limited Liability Partnership. The available information identifies his patent contribution but does not provide further details about his role or career history.
Collaborations
His listed coworkers include Moritz Schmidt and Philipp Knyphausen. The provided information does not specify the nature of their collaboration.
Conclusion
Wayne Coco’s documented innovation is his contribution to patent work on high-fidelity RNA-programmable endonuclease systems, associated with Casebia Therapeutics Limited Liability Partnership.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile